Lactobacillus lactis and Pediococcus pentosaceus‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease

BACKGROUND: Although microbioa‐based therapies have shown putative effects on the treatment of non‐alcoholic fatty liver disease (NAFLD), it is not clear how microbiota‐derived metabolites contribute to the prevention of NAFLD. We explored the metabolomic signature of Lactobacillus lactis and Pedioc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jeong Seok, Youn, Gi Soo, Choi, Jieun, Kim, Chang‐Ho, Kim, Byung Yong, Yang, Seung‐Jo, Lee, Je Hee, Park, Tae‐Sik, Kim, Byoung Kook, Kim, Yeon Bee, Roh, Seong Woon, Min, Byeong Hyun, Park, Hee Jin, Yoon, Sang Jun, Lee, Na Young, Choi, Ye Rin, Kim, Hyeong Seob, Gupta, Haripriya, Sung, Hotaik, Han, Sang Hak, Suk, Ki Tae, Lee, Do Yup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715831/
https://www.ncbi.nlm.nih.gov/pubmed/34965016
http://dx.doi.org/10.1002/ctm2.634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715831/
https://www.ncbi.nlm.nih.gov/pubmed/34965016
http://dx.doi.org/10.1002/ctm2.634

Ejemplares similares